RVBA-JRSPrivate

JRS Pharma

DE
no trajectory chart yet — needs at least one percent-reduction target with matching scope data

Headline intensities

·Values in USD ($)
Peer cohort: · lower is better
Revenue intensity
Carbon / $m revenue
tCO2e / $m revenue

Carbon per million dollars of revenue. The legacy industry-standard reference (CDP, MSCI). Useful for cross-sector context, but distorted by margin — high-margin firms appear artificially efficient. Read alongside the operational and asset intensities for the full picture.

Operational intensity
Carbon / $m OpEx
tCO2e / $m OpEx

OpEx (operating expenditure) is the running cost of the business — staff, services, energy, materials. This shows how carbon-intensive operations are per million dollars of spend. Removes the margin distortion that revenue-based ratios introduce.

Economic intensity
Carbon / $m EVIC
tCO2e / $m EVIC

EVIC (Enterprise Value Including Cash) is the firm's total capital footprint — equity + debt + cash + minority interest. The EU's standard intensity measure (SFDR PAI 3) — answers: how much carbon does each million of capital deployed in this business produce?

Asset intensity
Carbon / $m PP&E + leased
tCO2e / $m PP&E

PP&E (Property, Plant & Equipment) plus leased real-estate assets is the firm's physical infrastructure on the balance sheet. This shows the carbon intensity of that physical footprint — uses Scope 1+2+3 for consistency with the other headline intensities. Surfaces stranded-asset risk for asset-heavy firms.

No public sustainability disclosure

JRS Pharmadoesn't publish a sustainability report.

Private firms and small suppliers often don't disclose publicly. Drop your email and we'll reach out to the supplier on your behalf via our supplier data-request pipeline, then email you whatever they share back.

We’ll only use your email to notify you about this request.

No metric data yet for this company.